• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

TARGETED DISRUPTION OF CERULOPLASMIN GENE, AND ITS INFLUENCE ON PANCREATIC B CELL FUNCTION

Research Project

Project/Area Number 12671098
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Metabolomics
Research InstitutionYAMAGATA UNIVERSITY

Principal Investigator

DAIMON Makoto  YAMAGATA UNIVERSITY SCHOOL OF MEDICINE, THIRD DEPARTMENT OF INTERNAL MEDICINE ASSISTANT PROFESSOR, 医学部, 講師 (20241698)

Project Period (FY) 2000 – 2001
Project Status Completed (Fiscal Year 2001)
Budget Amount *help
¥900,000 (Direct Cost: ¥900,000)
Fiscal Year 2001: ¥900,000 (Direct Cost: ¥900,000)
KeywordsCERULOPLASMIN / GENE / DIABETES MELLITUS / HEREDITARY CERULOPLASMIN DEFICIENCY / 遺伝製セルロプラスミン欠損症
Research Abstract

The ceruloplasmin (Cp) gene has been shown to be responsible for hereditary Cp deficiency (HCD), which is an autosomal recessive disease characterized by neurological abnormalities. In many HCD cases, type 2 diabetes (DM) was the first symptom of the disease, and 10 - 20 years later at age 40 - 60 the neurological abnormalities occurred. Therefore, we made hypothesis that the Cp gene is a susceptible gene for DM, although the mechanisms involved in the pathogenesis of the development of DM are not clear at present. To clarify this hypothesis an, if it is true, the mechanisms, we first tried to make a mouse, which has targeted disruption of Cp gene (Cp knock out mouse: Cp -/-mouse). Then, this mouse can be used to clarify the mechanisms involved in the pathogenesis of the development of DM.
From a mouse genomic library, we screened 2 and 4 clones containing exon 1 and exons 2-4, respectively. These clones were used to make DNA construct. We finally made a DNA construct to knock out exons 2 and 3 of the Cp gene. This DNA construct contains PGK-neo and nLacZ-polyA for selection. We introduced this DNA construct to ES cells to make knock out mouse.

Report

(3 results)
  • 2001 Annual Research Report   Final Research Report Summary
  • 2000 Annual Research Report
  • Research Products

    (13 results)

All Other

All Publications (13 results)

  • [Publications] Satoko Moriai: "Hypoceruloplasminemia in neurological disease"Internal Medicine. 40・6. 548-549 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Makoto Daimon: "A novel mutation of the ceruloplasmin gene in a patient with heteroallelic ceruloplasmin gene mutation (HypoCPGM)"Tohoku Journal of Experimental Medicine. 191・3. 119-125 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Makoto Daimon: "Increase in serum ceruloplasmin with aging observed in type 2 diabetes"Endocrine Journal. 47・3. 215-219 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Makoto Daimon: "Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type2"Diabetes Care. 23・4. 559-560 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Satoko Moriai, et al.: "Hypoceruloplasminemia in neurological disease"Internal medicine. 40-6. 548-549 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Makoto Daimon, et al: "A novel mutation of the ceruloplasmin gene in a patient wih heteroallelic ceruloplasmin gene mutation (Hypo CPGM)"Tohoku J Exp Med. 191-3. 119-125 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Makoto Daimon, et al: "Increase in serum ceruloplasmin with aging is not observed in type 2 diabetes"Endocrine Journal. 47-3. 215-219 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Makoto Daimon, et al: "Increase in serum ceruloplasmin levels is correlated with a decrease of serum nitric oxide levels in type 2 diabetes"Diabetes Care. 23-4. 559-560 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2001 Final Research Report Summary
  • [Publications] Satoko Moriai: "Hypoceruloplasminemia in neurological disease"Internal medicine. 40・6. 548-549 (2001)

    • Related Report
      2001 Annual Research Report
  • [Publications] Makoto Daimon: "Increase in serum ceruloplasmin with aging is not observed in type 2 diabetes"Endocrine journal. 47・3. 215-219 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] Makoto Daimon: "A novel mutation of the ceruloplasmin gene in a patient with heteroallelic ceruloplasmin gene mutation(HypoCPGM)"Tohoku Journal of Experimental medicine. 191・3. 119-125 (2000)

    • Related Report
      2001 Annual Research Report
  • [Publications] Makoto Daimon: "Increase in serum Ceruloplasmin with aging is not observed in type 2 diabetes"Endocrine J. 47・3. 215-219 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Makoto Daimon: "A novel mutation of the ceruloplasmin gene in a patient with heteroallelic ceruloplasmin gene mutation (Hypo CPGM)"Tohoku Journal of Experimental Medicine. 191・3. 119-125 (2000)

    • Related Report
      2000 Annual Research Report

URL: 

Published: 2001-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi